132 related articles for article (PubMed ID: 15818637)
1. Regional variation in the prescribing for diabetes and use of secondary preventative therapies in Ireland.
Usher C; Bennett K; Feely J
Pharmacoepidemiol Drug Saf; 2005 Aug; 14(8):537-44. PubMed ID: 15818637
[TBL] [Abstract][Full Text] [Related]
2. Inequalities in prescribing of secondary preventative therapies for ischaemic heart disease in Ireland.
Bennett KE; Williams D; Feely J
Ir Med J; 2002 Jun; 95(6):169-72. PubMed ID: 12171263
[TBL] [Abstract][Full Text] [Related]
3. Prescribing for patients with diabetes in the community drug schemes.
Usher C; Creed L; Bennett K; Feely J
Ir Med J; 2006 Jun; 99(6):181-3. PubMed ID: 16921826
[TBL] [Abstract][Full Text] [Related]
4. Evidence for a gender and age inequality in the prescribing of preventative cardiovascular therapies to the elderly in primary care.
Usher C; Bennett K; Feely J
Age Ageing; 2004 Sep; 33(5):500-2. PubMed ID: 15315919
[No Abstract] [Full Text] [Related]
5. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
Vermeer NS; Bajorek BV
J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
[TBL] [Abstract][Full Text] [Related]
6. Trends in the use of lipid-lowering drugs by outpatients with diabetes in Taiwan, 1997-2003.
Chiang CW; Chiu HF; Chen CY; Wu HL; Yang CY
Pharmacoepidemiol Drug Saf; 2008 Jan; 17(1):62-9. PubMed ID: 17924453
[TBL] [Abstract][Full Text] [Related]
7. Trends in the use of antihypertensive drugs by outpatients with diabetes in Taiwan, 1997-2003.
Chiang CW; Chen CY; Chiu HF; Wu HL; Yang CY
Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):412-21. PubMed ID: 17252613
[TBL] [Abstract][Full Text] [Related]
8. Initial uptake and evidence of safe prescribing practice with Buproprion (Zyban).
Williams D; Bennett K; Heery A; Feely J
Pharmacoepidemiol Drug Saf; 2004 Jun; 13(6):411-5. PubMed ID: 15170772
[TBL] [Abstract][Full Text] [Related]
9. Sex differences in inappropriate prescribing among elderly veterans.
Bierman AS; Pugh MJ; Dhalla I; Amuan M; Fincke BG; Rosen A; Berlowitz DR
Am J Geriatr Pharmacother; 2007 Jun; 5(2):147-61. PubMed ID: 17719517
[TBL] [Abstract][Full Text] [Related]
10. Under-prescribing of cardiovascular therapies for diabetes in primary care.
Bennett KE; Williams D; Feely J
Eur J Clin Pharmacol; 2003 Apr; 58(12):835-41. PubMed ID: 12698311
[TBL] [Abstract][Full Text] [Related]
11. Statins prescribing for the secondary prevention of ischaemic heart disease in Torino, Italy. A case of ageism and social inequalities.
Gnavi R; Migliardi A; Demaria M; Petrelli A; Caprioglio A; Costa G
Eur J Public Health; 2007 Oct; 17(5):492-6. PubMed ID: 17303583
[TBL] [Abstract][Full Text] [Related]
12. Risk modification for diabetic patients. Are other risk factors treated as diligently as glycemia?
Shah BR; Mamdani M; Jaakkimainen L; Hux JE
Can J Clin Pharmacol; 2004; 11(2):e239-44. PubMed ID: 15557673
[TBL] [Abstract][Full Text] [Related]
13. Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes.
Winkelmayer WC; Fischer MA; Schneeweiss S; Wang PS; Levin R; Avorn J
Am J Kidney Dis; 2005 Dec; 46(6):1080-7. PubMed ID: 16310574
[TBL] [Abstract][Full Text] [Related]
14. [Reasons for the under-use of secondary prevention therapies in coronary patients over the age of 70 years].
Cournot M; Cambou JP; Quentzel S; Danchin N
Ann Cardiol Angeiol (Paris); 2005 Dec; 54 Suppl 1():S17-23. PubMed ID: 16411647
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction.
Austin PC; Tu JV; Ko DT; Alter DA
CMAJ; 2008 Oct; 179(9):901-8. PubMed ID: 18936455
[TBL] [Abstract][Full Text] [Related]
16. A clustered randomized trial of the effects of feedback using academic detailing compared to postal bulletin on prescribing of preventative cardiovascular therapy.
Naughton C; Feely J; Bennett K
Fam Pract; 2007 Oct; 24(5):475-80. PubMed ID: 17670803
[TBL] [Abstract][Full Text] [Related]
17. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].
Fabian W; Majkowska L; Stefański A; Moleda P
Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program.
Lai HY; Hwang SJ; Chen YC; Chen TJ; Lin MH; Chen LK
Clin Ther; 2009 Aug; 31(8):1859-70. PubMed ID: 19808145
[TBL] [Abstract][Full Text] [Related]
19. Prescribing of antidiabetic therapies in Ireland: 10-year trends 2003-2012.
Zaharan NL; Williams D; Bennett K
Ir J Med Sci; 2014 Jun; 183(2):311-8. PubMed ID: 24013870
[TBL] [Abstract][Full Text] [Related]
20. Clinical interest: a study of the influence on general practitioners' prescribing.
Hansen DG; Dybdahl T; Jarbøl D; Vach W
Pharmacoepidemiol Drug Saf; 2007 Apr; 16(4):458-63. PubMed ID: 17286321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
